<cite id="wpolg"><p id="wpolg"><pre id="wpolg"></pre></p></cite>
      <dd id="wpolg"><font id="wpolg"><object id="wpolg"></object></font></dd>
      <cite id="wpolg"></cite>
      <address id="wpolg"><samp id="wpolg"></samp></address>
        
        
          <address id="wpolg"><listing id="wpolg"></listing></address>
          <cite id="wpolg"><p id="wpolg"></p></cite>
            <meter id="wpolg"><ins id="wpolg"></ins></meter>
            1. 人琴棋牌

              home
              • Research & Development

              Research & Development

              Main Development Pipelines

              As of Sept, 2017

              Product code Target Indication Dosage Form Development region Current Phase
              M1180B Asteatosis etc. Topical JP Feb, 2018 Approval
              M5180 Psoriasis vulgaris Topical US Jun, 2016 Filed
              M5210B Recurrent herpes simplex Oral JP Feb, 2018 Filed
              M5250 Pruritus with atopic dermatitis Injection JP PⅢ

              ※This table is based on non-consolidated data from Maruho Co., Ltd.

              Page top
              人琴棋牌